Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HerpMV: Acyclovir in Ventilated Patients With Pneumonia and HSV in BAL
NCT06134492Phase 3Recruiting
- Sponsor
- Universitätsklinikum Jena
- Start
- Feb 2024
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of aciclovir in herpes simplex virus infection, pneumonia, sponsored by Universitätsklinikum Jena. Started Feb 2024; status: recruiting.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus infectionpneumonia
Beyond the preview
Go deeper on NCT06134492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06134492.